- Home
- UPXI vs CYRX Comparison
UPXI vs CYRX Comparison
Compare UPXI & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UPXI
- CYRX
- Stock Information
- Founded
- UPXI 2018
- CYRX 1999
- Country
- UPXI United States
- CYRX United States
- Employees
- UPXI N/A
- CYRX N/A
- Industry
- UPXI Medicinal Chemicals and Botanical Products
- CYRX Biotechnology: Pharmaceutical Preparations
- Sector
- UPXI Health Care
- CYRX Health Care
- Exchange
- UPXI Nasdaq
- CYRX Nasdaq
- Market Cap
- UPXI 356.9M
- CYRX 365.5M
- IPO Year
- UPXI 2021
- CYRX N/A
- Fundamental
- Price
- UPXI $5.22
- CYRX $7.39
- Analyst Decision
- UPXI
- CYRX Strong Buy
- Analyst Count
- UPXI 0
- CYRX 9
- Target Price
- UPXI N/A
- CYRX $10.67
- AVG Volume (30 Days)
- UPXI 5.1M
- CYRX 530.3K
- Earning Date
- UPXI 05-16-2025
- CYRX 08-05-2025
- Dividend Yield
- UPXI N/A
- CYRX N/A
- EPS Growth
- UPXI N/A
- CYRX N/A
- EPS
- UPXI N/A
- CYRX N/A
- Revenue
- UPXI $16,562,327.00
- CYRX $232,134,000.00
- Revenue This Year
- UPXI $299.03
- CYRX N/A
- Revenue Next Year
- UPXI N/A
- CYRX $9.59
- P/E Ratio
- UPXI N/A
- CYRX N/A
- Revenue Growth
- UPXI 1378.83
- CYRX 11.75
- 52 Week Low
- UPXI $1.90
- CYRX $4.58
- 52 Week High
- UPXI $22.57
- CYRX $9.78
- Technical
- Relative Strength Index (RSI)
- UPXI 46.53
- CYRX 56.83
- Support Level
- UPXI $2.73
- CYRX $7.40
- Resistance Level
- UPXI $6.57
- CYRX $7.72
- Average True Range (ATR)
- UPXI 0.66
- CYRX 0.35
- MACD
- UPXI 0.35
- CYRX -0.02
- Stochastic Oscillator
- UPXI 77.74
- CYRX 45.83
About UPXI Upexi Inc.
Upexi Inc specializes in the development, manufacturing, and distribution of consumer products. It reaches consumers through its direct-to-consumer network, wholesale partnerships, and prominent third-party platforms like Amazon.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.